Notícias da área de saúde nos EUA

Immutep assegura Euro1.8M em dinheiro no crédito fiscal do governo francês para pesquisa

Immutep secures €1.8M cash in French government’s research tax credit
  • Immutep ( NASDAQ: IMMP ) anunciado Friday it has received €1.8M cash from the French government in research and development tax incentive payment.
  • The incentive comes under the government’s research tax credit scheme under which French companies conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure.
  • The biotech firm said it intends to use the proceeds to support the ongoing and planned global clinical development of eftilagimod alpha and the preclinical development of IMP761.
  • Estoque is up 5% in pre-market trading .
  • Anteriormente: Immutep gets Japanese patent for immunotherapy eftilagimod alpha combo

Para mais detalhes, veja:

Immutep secures €1.8M cash in French government’s research tax credit

Artigos relacionados

Verifique também
Fechar
Botão Voltar ao topo